196597-26-9 | (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide

Packsize	Purity	Availability	Price	Discounted Price
5mg	95%	in stock	$44.00	$31.00
25mg	95%	in stock	$71.00	$50.00
100mg	95%	in stock	$146.00	$103.00
250mg	95%	in stock	$203.00	$142.00
1g	95%	in stock	$434.00	$304.00

Description

• Catalog Number: AB51303
• Chemical Name: (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide
• CAS Number: 196597-26-9
• Molecular Formula: C16H21NO2
• Molecular Weight: 259.3434
• MDL Number: MFCD08067736
• SMILES: CCC(=O)NCC[C@@H]1CCc2c1c1CCOc1cc2

Computed Properties

• Complexity: 331
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 19
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 4
• XLogP3: 2.7

Literature

• Cardiovascular effects of melatonin receptor agonists.

  Expert opinion on investigational drugs 20121101

• Ramelteon dose escalation in a patient with substance misuse.

  Journal of clinical psychopharmacology 20121001

• Ramelteon ingestions reported to Texas poison centers, 2005-2009.

  The Journal of emergency medicine 20120901

• Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.

  Central nervous system agents in medicinal chemistry 20120901

• Emerging treatment for chronic migraine and refractory chronic migraine.

  Expert opinion on emerging drugs 20120901

• Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis.

  International journal of clinical practice 20120901

• Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.

  Molecular carcinogenesis 20120801

• Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.

  Chronobiology international 20120801

• Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.

  Clinical pharmacology and therapeutics 20120601

• Pharmacotherapy of insomnia.

  Expert opinion on pharmacotherapy 20120601

• [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].

  Nihon rinsho. Japanese journal of clinical medicine 20120601

• Melatonin and its analogs in insomnia and depression.

  Journal of pineal research 20120501

• [Delirium, insomnia in hospitalization and ramelteon].

  Nihon rinsho. Japanese journal of clinical medicine 20120501

• [Report of the 5th meeting of Japanese Child Sleep Association].

  No to hattatsu = Brain and development 20120501

• Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.

  CNS & neurological disorders drug targets 20120301

• Chronic ramelteon treatment in a mouse model of Alzheimer's disease.

  Archives italiennes de biologie 20120301

• Augmentation with ramelteon to achieve remission in geriatric major depression.

  Psychiatry and clinical neurosciences 20120201

• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

  Parkinson's disease 20120101

• Health care costs in US patients with and without a diagnosis of osteoarthritis.

  Journal of pain research 20120101

• Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.

  Current medicinal chemistry 20120101

• The relationship of primary health care use with persistence of insomnia: a prospective cohort study.

  BMC family practice 20120101

• Hypnotics' association with mortality or cancer: a matched cohort study.

  BMJ open 20120101

• Circadian and wakefulness-sleep modulation of cognition in humans.

  Frontiers in molecular neuroscience 20120101

• cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents.

  PloS one 20120101

• Gender differences in highway driving performance after administration of sleep medication: a review of the literature.

  Traffic injury prevention 20120101

• Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.

  TheScientificWorldJournal 20120101

• Recent progress in the development of agonists and antagonists for melatonin receptors.

  Current medicinal chemistry 20120101

• Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives.

  Journal of medicinal chemistry 20111222

• Melatonin receptor agonists: new options for insomnia and depression treatment.

  CNS neuroscience & therapeutics 20111201

• Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.

  Journal of clinical psychopharmacology 20111001

• Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.

  Sleep medicine 20111001

• Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.

  Expert review of neurotherapeutics 20111001

• The challenges of interpreting residual effects of hypnotics.

  Sleep 20111001

• Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.

  Sleep 20111001

• Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

  Therapeutic advances in neurological disorders 20110901

• An historical view of the pineal gland and mental disorders.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20110801

• Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.

  Journal of medicinal chemistry 20110623

• Ramelteon and improved insomnia in alcohol-dependent patients: a case series.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110615

• Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

  Progress in neuro-psychopharmacology & biological psychiatry 20110601

• Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration.

  Sleep medicine 20110601

• Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization.

  Current neuropharmacology 20110601

• 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.

  Journal of medicinal chemistry 20110512

• Insomnia: a therapeutic review for pharmacists.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110501

• Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.

  Bioorganic & medicinal chemistry letters 20110215

• Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.

  Journal of affective disorders 20110201

• Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.

  Chronobiology international 20110201

• Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.

  Sleep medicine 20110201

• Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.

  Sleep medicine 20110201

• Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.

  Expert review of neurotherapeutics 20110201

• A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.

  International clinical psychopharmacology 20110101

• Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

  International journal of Alzheimer's disease 20110101

• Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.

  Research in developmental disabilities 20110101

• Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.

  Neuroendocrinology 20110101

• Pharmacological advances in the treatment of insomnia.

  Current pharmaceutical design 20110101

• Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm?

  Journal of the American Society of Hypertension : JASH 20110101

• Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP).

  International journal of general medicine 20110101

• Melatonin in mitochondrial dysfunction and related disorders.

  International journal of Alzheimer's disease 20110101

• Clinical uses of melatonin in pediatrics.

  International journal of pediatrics 20110101

• Treatment of delirium with ramelteon: initial experience in three patients.

  General hospital psychiatry 20110101

• Efficient synthesis of [¹¹C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms.

  Chemical & pharmaceutical bulletin 20110101

• Prevalence and factors associated with off-label antidepressant prescriptions for insomnia.

  Drug, healthcare and patient safety 20110101

• Melatonin in Chagas' disease. Possible therapeutic value.

  Medicina 20110101

• Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin.

  Neuro endocrinology letters 20110101

• Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215

• Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215

• Melatonin alters age-related changes in transcription factors and kinase activation.

  Neurochemical research 20101201

• Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs.

  Advances in therapy 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.

  Current drug metabolism 20101101

• Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.

  Neurocase 20101001

• Melatonin: pharmacological aspects and clinical trends.

  The International journal of neuroscience 20100901

• [The newer sedative-hypnotics].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901

• Neurotoxins: free radical mechanisms and melatonin protection.

  Current neuropharmacology 20100901

• A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

  Current neuropharmacology 20100901

• Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics.

  Drug metabolism and disposition: the biological fate of chemicals 20100801

• [Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701

• Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.

  Sleep medicine 20100601

• Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep.

  Sleep 20100601

• Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats.

  Annals of the New York Academy of Sciences 20100601

• A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.

  International clinical psychopharmacology 20100501

• Potential use of melatonergic drugs in analgesia: mechanisms of action.

  Brain research bulletin 20100316

• MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).

  Endocrinology 20100201

• Melatonin agonists and insomnia.

  Expert review of neurotherapeutics 20100201

• Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.

  BMC medicine 20100101

• Diagnosis and treatment of chronic insomnia.

  Annals of Indian Academy of Neurology 20100101

• Insomnia medication use and the probability of an accidental event in an older adult population.

  Drug, healthcare and patient safety 20100101

• Indian research on sleep disorders.

  Indian journal of psychiatry 20100101

• Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.

  Brain research 20091103

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091101

• Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.

  The Journal of pharmacology and experimental therapeutics 20090901

• Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.

  Epilepsy & behavior : E&B 20090901

• Treatment of sleep dysfunction and psychiatric disorders.

  Current treatment options in neurology 20090901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090901

• Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem).

  P & T : a peer-reviewed journal for formulary management 20090901

• Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815

• [A novel therapeutic drug: ramelteon].

  Nihon rinsho. Japanese journal of clinical medicine 20090801

• Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

  Psychopharmacology 20090701

• Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.

  Neuroscience letters 20090626

• Emerging therapies for sleep disorders.

  British journal of hospital medicine (London, England : 2005) 20090601

• Ramelteon: a review of its therapeutic potential in sleep disorders.

  Advances in therapy 20090601

• Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.

  Prescrire international 20090601

• Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.

  Current medical research and opinion 20090501

• Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.

  The Journal of clinical psychiatry 20090401

• [Objection to a conclusion in Medicinske Nyheder].

  Ugeskrift for laeger 20090330

• The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.

  Sleep & breathing = Schlaf & Atmung 20090301

• Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.

  Human psychopharmacology 20090301

• Ramelteon for the treatment of insomnia in menopausal women.

  Menopause international 20090301

• Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

  Sleep 20090301

• Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215

• Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215

• Let there be sleep--on time.

  Lancet (London, England) 20090207

• The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• The effects of ramelteon in a first-night model of transient insomnia.

  Sleep medicine 20090101

• Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.

  CNS neuroscience & therapeutics 20090101

• Melatonin and melatonergic drugs on sleep: possible mechanisms of action.

  The International journal of neuroscience 20090101

• New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.

  Neuropsychiatric disease and treatment 20090101

• Comparative tolerability of newer agents for insomnia.

  Drug safety 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Algorithms for the assessment and management of insomnia in primary care.

  Patient preference and adherence 20090101

• Can improving sleep influence sleep-disordered breathing?

  Drugs 20090101

• Neurophysiology of sleep and wakefulness: basic science and clinical implications.

  Current neuropharmacology 20081201

• Circadian phase-shifting effects of repeated ramelteon administration in healthy adults.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20081015

• Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.

  Critical care medicine 20081001

• Melatonin and its agonists: an update.

  The British journal of psychiatry : the journal of mental science 20081001

• The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.

  Sleep 20081001

• Ramelteon: new drug. Insomnia: no role for risky placebos.

  Prescrire international 20081001

• Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.

  Neuroscience 20080909

• Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.

  Journal of pineal research 20080901

• Ramelteon: a novel approach in the treatment of insomnia.

  The Annals of pharmacotherapy 20080901

• Sleep dysfunction in heart failure.

  Current treatment options in neurology 20080901

• Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep?

  Journal of sleep research 20080901

• Possibility that certain hypnotics might cause cancer in skin.

  Journal of sleep research 20080901

• Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.

  Sleep & breathing = Schlaf & Atmung 20080801

• Efficacy and clinical safety of ramelteon: an evidence-based review.

  Sleep medicine reviews 20080801

• Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.

  Neuroscience letters 20080704

• Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.

  Clinical therapeutics 20080701

• Pharmacotherapy for insomnia.

  Clinics in geriatric medicine 20080201

• A review of ramelteon in the treatment of sleep disorders.

  Neuropsychiatric disease and treatment 20080201

• [Drugs for insomnia and improving quality of life (QOL): research and development of ramelteon, an MT1/MT2-receptor agonist].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080101

• Ramelteon: a melatonin receptor agonist for the treatment of insomnia.

  Journal of postgraduate medicine 20080101

• Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.

  Travel medicine and infectious disease 20080101

• Melatonergic drugs in clinical practice.

  Arzneimittel-Forschung 20080101

• Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.

  Critical care (London, England) 20080101

• Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders.

  Current topics in medicinal chemistry 20080101

• Ramelteon: a review of its use in insomnia.

  Drugs 20080101

• Indiplon in the treatment of sleep disorders.

  Neuropsychiatric disease and treatment 20071201

• In search of novel and therapeutically significant melatoninergic ligands.

  Recent patents on CNS drug discovery 20071101

• Design and synthesis of new N1 and C3-substituted 4-fluoroindolic melatoninergics.

  Current drug discovery technologies 20071001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071001

• Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.

  Sleep & breathing = Schlaf & Atmung 20070901

• Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.

  The American journal of geriatric pharmacotherapy 20070901

• Eszopiclone for late-life insomnia.

  Clinical interventions in aging 20070901

• Ramelteon: a novel hypnotic indicated for the treatment of insomnia.

  Psychiatry (Edgmont (Pa. : Township)) 20070901

• Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815

• Treatment options for insomnia.

  American family physician 20070815

• Putting 'sleepdriving' and new safety warning in perspective.

  The Johns Hopkins medical letter health after 50 20070801

• Eszopiclone: its use in the treatment of insomnia.

  Neuropsychiatric disease and treatment 20070801

• New perspectives for the treatment of disorders of sleep and arousal.

  Annales pharmaceutiques francaises 20070701

• Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.

  Current medical research and opinion 20070601

• The management of insomnia in the older adult.

  Medicine and health, Rhode Island 20070601

• Hypnotic sedative drugs.

  Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20070601

• A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

  Current medical research and opinion 20070501

• Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2.

  Journal of clinical pharmacology 20070401

• Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.

  Nature clinical practice. Neurology 20070401

• Putting insomnia to rest.

  The Nurse practitioner 20070401

• Therapeutic options for sleep-maintenance and sleep-onset insomnia.

  Pharmacotherapy 20070101

• [Recent and potential drugs for treatment of insomnia].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070101

• Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

  CNS drugs 20070101

• [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].

  Pharmazie in unserer Zeit 20070101

• Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Greater incidence of depression with hypnotic use than with placebo.

  BMC psychiatry 20070101

• Role of the melatonin system in the control of sleep: therapeutic implications.

  CNS drugs 20070101

• [New hypnotics: perspectives from sleep physiology].

  Vertex (Buenos Aires, Argentina) 20070101

• Treating insomnia: Current and investigational pharmacological approaches.

  Pharmacology & therapeutics 20061201

• Pharmacologic management of insomnia: past, present, and future.

  The Psychiatric clinics of North America 20061201

• Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

  Archives of general psychiatry 20061001

• Ramelteon for insomnia in two youths with autistic disorder.

  Journal of child and adolescent psychopharmacology 20061001

• Ramelteon for the treatment of insomnia.

  Clinical therapeutics 20061001

• A new sleeping pill.

  The Harvard mental health letter 20061001

• Treatment of sleep dysfunction and psychiatric disorders.

  Current treatment options in neurology 20060901

• Associated Professional Sleep Societies--SLEEP 2006 20th Anniversary Meeting. 17-22 June 2006, Salt Lake City, UT, USA.

  IDrugs : the investigational drugs journal 20060901

• Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.

  Journal of psychiatric practice 20060901

• New drugs 06, part II.

  Nursing 20060801

• Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.

  Neuroscience letters 20060724

• Ramelteon: a novel treatment for the treatment of insomnia.

  Expert review of neurotherapeutics 20060701

• Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?

  Journal of psychiatric practice 20060701

• Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

  Sleep medicine 20060601

• Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.

  Behavioral neuroscience 20060601

• Management of chronic insomnia in elderly persons.

  The American journal of geriatric pharmacotherapy 20060601

• Depression and sleep: pathophysiology and treatment.

  Dialogues in clinical neuroscience 20060601

• Consultation corner. Are the new sleep aids right for you?

  The Johns Hopkins medical letter health after 50 20060401

• Potential therapeutic use of melatonin in migraine and other headache disorders.

  Expert opinion on investigational drugs 20060401

• Ramelteon (rozerem) a novel approach for insomnia treatment.

  The Nurse practitioner 20060401

• Practical considerations of new drugs: new choices for old problems.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401

• Ramelteon: profile of a new sleep-promoting medication.

  Drugs of today (Barcelona, Spain : 1998) 20060401

• Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.

  Journal of clinical pharmacology 20060201

• A look back at the most influential drug approvals of 2005.

  The Nurse practitioner 20060201

• Recommendations for assessing insomnia.

  The Nurse practitioner 20060201

• An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

  Sleep medicine 20060101

• New drugs: ramelteon, tipranavir, nepafenac, and deferasirox.

  Journal of the American Pharmacists Association : JAPhA 20060101

• Use of sleep-promoting medications in nursing home residents : risks versus benefits.

  Drugs & aging 20060101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060101

• Melatonin and sleep in aging population.

  Experimental gerontology 20051201

• Ramelteon (Rozerem) for insomnia.

  The Medical letter on drugs and therapeutics 20051107

• Fresh from the pipeline: Ramelteon.

  Nature reviews. Drug discovery 20051101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051001

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050915

• Recent advances in melatonin receptor ligands.

  Archiv der Pharmazie 20050601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050401

• Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.

  Sleep 20050301

• Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats.

  Journal of biological rhythms 20050201

• Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.

  Neuropharmacology 20050201

• TAK-375 Takeda.

  Current opinion in investigational drugs (London, England : 2000) 20050101

• Ramelteon: TAK 375.

  Drugs in R&D 20050101

• Ramelteon.

  CNS drugs 20050101

• Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults.

  The Journal of clinical psychiatry 20050101

• Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.

  The Journal of clinical psychiatry 20050101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041201

• Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.

  Brain research 20041119

• Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists.

  Sleep medicine 20041101

• The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.

  Sleep 20041101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20031101

• Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.

  Journal of medicinal chemistry 20020912